SUMMARY
It has previously been demonstrated that haemodilution provokes an increase in whole blood coagulation. Tocantins in 1951 1 and Monkhouse in 1959 2 reported that moderate haemodilution with crystalloids could induce a hypercoagulable state. This was later borne out by Janvrin 3 in a clinical trial that showed an increased incidence of postoperative deep vein thrombosis related to intraoperative fluid administration. We have shown, in vitro 4 and in vivo 5 , that haemodilution with 0.9% saline and other crystalloid solutions 6 causes enhanced coagulation as measured by the thrombelastograph (TEG ® , Manta Medical Systems) and routine coagulation studies. While this has been confirmed by numerous other authors [7] [8] [9] [10] , the mechanism has not been described. Monkhouse originally postulated an imbalance between the formation of active coagulants and the activity of anticoagulants as being responsible for the enhanced clotting demonstrated after haemodilution. Support for this concept came from a previous in vivo study 5 which demonstrated a reduction in antithrombin III (AT III) concentrations greater than was expected by dilution alone. This study demonstrated that the enhanced coagulation resulting from haemodilution is at least partially the result of reducing the levels of active anticoagulant, while leaving the capacity of pro-coagulants (which exist as unactivated precursors) unchanged. A decreased level of anticoagulant factors will lower the threshold for the initiation of the positive thrombin feedback loop.
Nearly 20 years ago, Nossel and co-workers demonstrated that activated fibrinopeptides are continuously being formed in plasma, and concluded that, in vivo, normal plasma contains idling levels of thrombin 11, 12 . Jesty and co-workers 13 have proposed that inhibition plays a role in the positive feedback of the coagulation cascades as a result of the control exercised by inhibitors such as AT III and heparin cofactors (40 to 50%), α 2 macroglobulin (20%) and others (30%)-of which the most likely is the α 1 protease inhibitor-confering threshold properties on the system 14 . The balance between activated coagulation factors and coagulation inhibitors results in a threshold level below which no response will occur, while above the threshold the response should be at, or near, maximum. The ability of the entire system to cope with idling, non-zero levels of activated clotting enzymes, without generating a response, implies that the balance of intra-vascular coagulation is protected against sub-threshold stimuli. The second order kinetics of the action of AT III mean that the rates of inhibition of its target enzymes are a function of its concentration [13] [14] [15] . Clinical evidence has shown that a decrease in concentration of AT III to below 70% of normal is linked to an increased risk of thrombosis, particularly venous thrombosis 3 . Since at this level there is still a mass excess of AT III relative to thrombin, partial inhibitor deficiency is likely to be a kinetic rather than a capacity defect.
We have conducted an in vitro study, using the thrombelastograph, to test the hypothesis that the enhancement of coagulation by haemodilution could be due to a reduction in the concentration of the anticoagulants, while having no effect on the levels of continuous spontaneously formed activated coagulants, predominantly thrombin.
MATERIALS AND METHODS
The University of Cape Town's Research Ethics Committee approved this experiment. Blood samples were obtained from 20 healthy, conscious volunteers, taken from a free-flowing forearm vein using a twosyringe technique. The first 3 ml of blood drawn from the needle were discarded; then, using a fresh syringe, 16 ml blood were drawn and separated into four aliquots of 4 ml each in polypropylene plastic tubes. One sample was left undiluted and served as a control (C). Another was diluted by 20% with the addition of 1 ml of 0.9% saline to demonstrate the previously documented enhanced coagulation (S). The third sample was diluted with 1 ml of 0.9% saline to which two units of AT III had been added to achieve a calculated level within the normal range (70 to 130%) of AT III in the diluent (SA). The fourth remained undiluted, but had two units of AT III (in a volume of 40 µl) added to it (CA). Specimen tubes, containing each of the four samples, were inverted several times to ensure thorough and similar mixing of the blood in each tube. As far as possible, each sample was treated in a similar fashion. Specimens from each sample tube (0.360 ml) were then placed in the TEG cuvette within four minutes of venesection and simultaneous traces recorded of the normal blood sample and of the various test-samples. The TEG trace was recorded for one hour and the r-and k-times, alpha angle (α), and maximum amplitude (MA) were measured for each sample.
In order to validate our calculation of the AT III content in the diluted samples, a further experiment was conducted. In five subjects, AT III concentrations were compared between control and 20% saline dilution, and between control and 20% saline plus AT III dilution.
Statistics
Statistical analysis was performed using the Statistica ® package running under Windows 98 on an IBM compatible computer. Data obtained from each group were compared using analysis of variance with the LSD test used for post-hoc identification of significantly different groups. Power analysis using anticipated differences and standard deviations obtained from our previous work indicated that sample size of 20 would have 90% power to detect 20% difference in TEG variables. Data were further analyzed by calculating the variation of each group from its control value, and differences were again tested using ANOVA and the LSD test.
RESULTS
The 20% dilution of whole blood with saline alone (group S) resulted in a significant enhancement of coagulation as measured by the TEG, in line with our previous observations. The dilution of whole blood by 20% with saline containing two units of AT III (group SA) resulted in an r-time that was not significantly different from that of the undiluted control (group C), or from that of the undiluted sample to which two units of AT III had been added (group CA); however it was significantly different from group S ( Table 1) .
The k-time obtained from group SA was significantly shorter (showing increased rate of clot formation) than that obtained from either group C or group CA. There was a trend towards a difference in k-time in the saline/AT III group (group SA) compared to pure saline group (group S), suggesting that the rate of clot formation, whilst still accelerated, was slightly slower than in group S, but this did not achieve statistical significance (P=0.051).
There was a significant increase in alpha angle in group S as compared to groups C and CA (P<0.001). There was a trend towards an increased alpha angle in group SA compared to group C (P=0.06) and group CA (P=0.052), but this did not reach statistical significance. There was no significant difference in alpha angle between group S and group SA.
The maximum amplitude was not changed significantly in any of the groups.
The addition of two units of AT III to an otherwise undiluted sample of whole blood had no effect on coagulation variables compared to those obtained from the untreated control sample, i.e., group CA was not different from group C in any respect.
All changes from control values are shown in Figure 1 . The change in r-time produced by saline was significantly different from that produced by saline + AT III, as well as significantly different from both AT III alone or zero. The changes in k-time produced by both saline and saline+AT III were different from zero and from that produced by AT III alone; they also approached significant differences from each other. Saline produced a change in alpha angle that was significantly different from zero (C) and AT III (CA), and also greater than saline+AT III (SA); saline+AT III produced a change that was significantly different from that in group CA, but not different from zero. There were no changes in MA. The addition of AT III alone produced no change in any of the TEG measures compared to control.
The changes from control in AT III concentrations after 20% saline dilution, as well as saline+AT III dilution, are reflected in Table 2 . There was an 16 . It was re-evaluated in the surgical setting in 1974 17 . Subsequently, it was further developed in various areas [18] [19] [20] [21] [22] [23] . In general, the TEG measures the coagulation process in whole blood, rather than testing the activity of coagulant factors in anticoagulated plasma, as is commonly done in conventional analysis of coagulation profiles.
When a blood vessel is damaged, it is essential that the final products of the haemostatic system are restricted to the site of damage. The entire clotting process, from its initiation through to fibrin production, must therefore be spatially restricted in the vasculature. Thrombin generation is the central biochemical reaction in both normal haemostasis and thrombosis. The production of thrombin is selfreinforcing because of its feedback activation of numerous coagulation proteins (factor V, VIII, XI, and VII) that contribute to thrombin production. Positive feedback in coagulation constitutes a major part of the architecture of the system. Thrombin is also involved in other pathways, like platelet aggregation and in the stimulation of the fibrinolytic pathway 24 . However, the positive feedback of thrombin into the intrinsic pathway is the most important factor, as once it has overcome the anticoagulant induced threshold, it results in an exponential increase of further thrombin formation, thus insuring that a clot is formed. The prime factor regulating the activation of thrombin is AT III.
Our findings in this study can be summarized as follows: (a) 20% haemodilution with saline causes an enhancement of coagulation; (b) the addition of AT III to normal blood has no effect on coagulation; (c) addition of AT III to the diluent to maintain the post-dilutional blood concentrations at pre-dilution levels inhibits the enhancement of coagulation normally produced by dilution. The diminished, but still present, shortening of the k-time in the saline plus AT III group implies that, once begun, coagulation again becomes exponentially increased despite normal levels of AT III.
These findings strongly suggest that the mechanism of the well described haemodilution-enhanced coagulation is related to the dilution of the anticoagulant factors, of which AT III is the most important, while not effecting the continuous autologous formation of activated AT III.
It has been described that the activated coagulants are continuously being spontaneously formed 12 , but make up only a minute fraction of the total amount of pro-coagulants 11 . We have previously shown that haemodilution decreases the levels of AT III 5 and possibly other inhibitors of coagulation. This will result in the threshold for initiation of positive feedback into the coagulation cascade being lowered, resulting in exponentially stimulated coagulation via the intrinsic pathway. In other words, haemodilution enhances thrombus formation by dilution of inhibitors of coagulation, while having a minimal effect on the level of continuously formed active coagulants even though the concentration of procoagulant factors are also decreasing in proportion to the anticoagulant decrease 2 . This then results in unchecked positive feedback, and accelerated formation of thrombin.
This study has demonstrated that when the concentration of AT III is maintained within the normal range in the diluent, thus partially maintaining the coagulation threshold post-dilution, the effect of enhanced coagulability due to dilution, can be attenuated, but not inhibited completely. It must, however, be taken into account that AT III is only one of several inhibitors of positive feedback 25 acting on the coagulation cascade, accounting for between 40 and 50% of the effect. It is therefore possible to speculate that one could produce greater attenuation of this enhanced coagulation by keeping the levels of the other naturally occurring inhibitors of coagulation constant as well.
We conclude that this study confirms the widely observed effect of enhanced coagulation after moderate haemodilution. More importantly, it demonstrates for the first time, that the pathway of this effect is likely to be on the basis of decreased concentrations of the coagulation inhibitors, while having no effect on the spontaneous formation of activated coagulants. The decrease in the concentration of the inhibitors in turn reduces the threshold at which AT III activity (expressed as percentage of standardized normal activity) in the control samples, samples diluted 20% with plain saline and samples diluted 20% with saline plus AT III (n=5). *P<0.01 for differences between saline diluted samples, and both control samples and samples diluted with saline+AT III.
positive feedback occurs along the coagulation pathway, thus leading to the unopposed exponential propagation of a thrombus.
